Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Folate intake

This article was originally published in The Tan Sheet

Executive Summary

Folate intake: Aug. 6 public meeting will focus on folate's role in the prevention of neural tube birth defects and "encourage and provide guidance to attendees" in the "dissemination of a public health message about adequate folate intake" for women of child-bearing age, according to a notice published in the July 9 Federal Register. Jointly sponsored by the Centers for Disease Control & Prevention and the March of Dimes Birth Defects Foundation, the meeting will take place from 10 a.m. to noon at HHS headquarters. For further information, contact FDA's Jeanne Latham at 202/205-4697...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087295

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel